GlassScriptPhysician profile
Billy R Preece
NPI 1417525759
$2,139.88
in general payments reported to CMS, 2019-2025
11 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.20 · 2023: $13.63 · 2024: $1,824 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,361 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,361.30 |
| Food and Beverage | $752.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,654.76 | 2024 | |
| Aroa Biosurgery Incorporated | $222.51 | 2024-2025 | |
| Teleflex LLC | $110.13 | 2024 | Quikclot |
| Acera Surgical, INC. | $28.92 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $28.28 | 2025 | Prevena, Abthera, V.A.C. Veraflo |
| Amgen INC. | $25.61 | 2022-2023 | Evenity, Prolia |
| Alcresta Therapeutics, INC. | $21.60 | 2025 | Relizorb |
| Kerecis Limited | $18.28 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Davol INC. | $15.57 | 2025 | Arista |
| Orthofix Medical, INC. | $14.22 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Preece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.